The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Docetaxel 20mg/ml concentrate for solution for infusion

20 milligram(s)/millilitre Concentrate for solution for infusion

Accord Healthcare Ireland Ltd.PA2315/125/001

Main Information

Trade NameDocetaxel 20mg/ml concentrate for solution for infusion
Active SubstancesDocetaxel
Strength20 milligram(s)/millilitre
Dosage FormConcentrate for solution for infusion
Licence HolderAccord Healthcare Ireland Ltd.
Licence NumberPA2315/125/001

Group Information

ATC CodeL01CD Taxanes
L01CD02 docetaxel

Status

Authorised/WithdrawnAuthorised
Licence Issued24/09/2010
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back